Camden Property Trust amends credit agreement, extends facility maturity to 2030

Camden reported Q4 2025 EPS of $1.44 versus $0.35 consensus while revenue slightly missed at $390.79M versus $393.39M. The company signed a Fifth Amended and Restated Credit Agreement (Mar 17), removed a $300M delayed‑draw term loan and extended its revolver maturity to March 2030 (with two six‑month extension options); it also priced $600M of senior unsecured notes at a 4.900% coupon due Feb 28, 2036. Management expects to use proceeds and potential $1.6–$2.0B from Southern California asset sales for acquisitions and share repurchases; Camden yields 4.23% with 34 consecutive years of dividends, and Truist reiterated a Buy with a $118 PT despite lowering 2026/27 FFO estimates.

Analysis

Camden’s recent capital moves shift the battle from near-term liquidity risk to execution risk on capital recycling. By creating dry powder and signaling buyback/firepower, management can accelerate FFO per share improvement without organic rent acceleration; that amplifies short-term EPS optics but raises leverage and execution sensitivity if reinvestment yields < cost of capital. Expect competitors with heavier exposure to gateway coastal portfolios to feel pressure on cap-rate comps and M&A pricing — buyers will need to beat Camden’s implied hurdle or sit on lower-return deals.

The dominant macro tailwind is a benign funding backdrop and stable employment driving apartment demand over the next 6–18 months; the dominant tail risk is a 75–150bp re‑acceleration in policy rates or a localized rent deterioration in key West Coast submarkets within 3–9 months. A ratings downgrade or bank-market sentiment shift could re-price Camden’s credit spread quickly, turning an earnings-accretive buyback into a leverage sell signal. Watch development absorption rates and same-store NOI as 60–120 day leading indicators for profitability stress.

Consensus is focused on the EPS pop and buyback optionality; the overlooked dynamic is option value erosion from aggressive asset sales — selling trophy coastal stock when cap rates are at troughs reduces long-term growth runway even if it boosts near-term returns. That divergence creates a two-tier trade: front‑loaded EPS upside vs multi-year organic growth risk, which is exploitable with calibrated equity and option strategies over 3–12 month horizons.

Key Decisions for Investors

• Long CPT equity + protective put (defined risk): Buy CPT shares size 1–2% NAV, hedge with a 6‑month put 10% OTM to cap downside; target 15–25% upside in 6–12 months if buybacks/accretive deals continue, stop-loss if shares drop 12% unhedged (put delta provides buffer).
• Pair trade (carry down macro beta): Go long CPT and short EQR (equal dollar) for 3–9 months to isolate execution/tenant-market spread; target relative outperformance of 8–12% if Camden’s capital redeployment proves accretive, unwind if spread in same‑store NOI between the two widens beyond 200bps.
• Covered-call income alternative: Buy CPT and sell a 9–12 month out‑of‑the‑money covered call ~20% above entry to finance carry if conviction is tactical (reduces cost basis and monetizes buyback optimism); accept capped upside in exchange for immediate yield enhancement of 3–5% annualized.
• Short tactical on execution failure (tail hedge): Small, size-limited short position in higher-leverage regional multifamily REITs that will be forced to refinance sooner — horizon 3–12 months; target asymmetric payoff if rates spike or spreads widen, limit position to 0.5% NAV and cut if 30-day rolling default distance improves.